Insulin-Like Growth Factor-I in Cerebrospinal Fluid and Serum in Rett Syndrome

Abstract

Rett syndrome is a neurodevelopmental disease characterized by failure of somatic and brain growth. The insulin-like growth factor system mediates most actions of growth hormone. Evidence that it plays an important role in early development of the brain is increasing. The aim of the study reported was to assess the role of the insulin-like growth factor system in the pathogenesis of Rett syndrome. We measured insulin-like growth factor-I levels in serum (8 patients, mean age 9.1 years) and cerebrospinal fluid (13 patients, mean age 7 years) using a sensitive radioimmunoassay method and compared them with those in age-matched controls (13 and 26 patients, respectively). Neither serum nor cerebrospinal fluid insulin-like growth factor-I levels differed from those in controls. We also measured insulin-like growth factor binding protein-3 levels in serum (in 9 patients and 8 controls) and in cerebrospinal fluid (in 12 patients and 11 controls) and serum growth hormone levels (in 8 patients and 11 controls); the levels in patients did not differ from those in controls. We found no significant correlation between serum and cerebrospinal fluid insulin-like growth factor-I in Rett syndrome. This may indicate an independent role of insulin-like growth factor system in the central nervous system, making serum insulin-like growth factor-I measurement unreliable as an indicator of disturbed function in the central nervous system. Our results did not support the notion that a defective insulin-like growth factor-I system explains the lack of somatic and brain growth in Rett syndrome. (J Child Neurol 2000;15:797-802).

Get full access to this article

View all access options for this article.

References

Amir EA , Van den Veyver IB , Wan M. , et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat Genet 1999 ;23:185-188.

The Rett Syndrome Diagnostic Criteria Work Group : Diagnostic criteria for Rett syndrome. Ann Neurol 1988;23:425-428.

Percy AK : Neurochemistry of the Rett syndrome. Brain Dev 1992; 14(Suppl):57-62.

Schultz RJ , Glaze DG , Motil KJ , et al: The pattern of growth failure in Rett syndrome. Am J Dis Child 1993;147:633-637.

Hagberg B. : Clinical criteria, stages and natural history, in Hagberg B (ed): Rett Syndrome - Clinical and Biological Aspects. London, Mac Keith Press , 1993, 4-20.

Riederer P. , Wieser M. , Wichart I. , et al: Preliminary brain autopsy findings in progredient Rett syndrome . Am JMed Genet 1986;24: 305-315.

Jellinger K. , Armstrong D. , Zoghbi HY , Percy AK : Neuropathology of Rett syndrome. Acta Neuropa thol 1988; 76:142-158.

Armstrong DD: The neuropathology of Rett syndrome — Overview 1994. Neuropediatrics 1995;26:100-104.

Wenk G. : Rett syndrome: Evidence for normal dopaminergic function. Neuropediatrics 1996;27:256-259.

10.

Belichenko PV , Hagberg B. , Dahlström A. : Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol 1997;93: 50-61.

11.

Hagberg B. : Rett syndrome: Clinical peculiarities and biological mysteries. Acta Paediatr 1995;84:971-976.

12.

Naidu S. : Rett syndrome: A disorder affecting early brain growth. Ann Neurol 1997;42:3-10.

13.

Hanefeld F. , Hagberg B. , Percy A. : Molecular and neurobiology aspects of Rett syndrome. Neuropediatrics 1995;26:60-61.

14.

Kitt CA , Troncoso JC , Price DL , et al: Pathological changes in substantia nigra and basal forebrain cholinergic neurons in Rett syndrome. Ann Neurol 1990;28:416-417.

15.

Wenk G. : Selective changes in Rett syndrome neurochemistry: Findings of normal dopaminergic and decreased cholinergic function. Eur J Adolesc Psychiatry 1997;6(Suppl 1):87-88.

16.

Lappalainen R. , Lindholm D. , Riikonen R. : Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 1996;11:296-300.

17.

Vanhala R. , Korhonen L. , Mikelsaar M. , et al: Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome. J Child Neurol 1998; 13:429-433.

18.

Han Vkm : Is the central nervous system a target for growth hormone and insulin-like growth factors? Acta Paediatr Suppl 1995; 411:3-8.

19.

Tham A. , Nordberg A. , Grissom FE , et al: Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm 1993;5:165-176.

20.

Shalet SM , Toogood A. , Rahim A. , Brennan Bmd : The diagnosis of growth hormone deficiency in children and adults. Endocrinol Rev 1998; 19:203-223.

21.

Cimaz R. , Rusconi R. , Cesana B. , et al: A multicenter study on insulin-like growth factor-I serum levels in children with chronic inflammatory diseases. Clin Exp Rheumatol 1997;15:691-696.

22.

Armstrong DD : The neuropathology of the Rett syndrome. Brain Dev 1992;14(Suppl):89-98.

23.

Budden SS : Rett syndrome: Studies of 13 affected girls. Am J Med Genet 1986;24:99-109.

24.

Hagberg B. : Rett syndrome: Clinical peculiarities, diagnostic approach, and possible cause . Pediatr Neurol 1989;5:75-83.

25.

Thommesen M. , Kase BF , Heiberg A. : Growth and nutrition in 10 girls with Rett syndrome. Acta Paediatr 1992;81:686-690.

26.

Motil KJ , Schultz RJ , Wong WW , Glaze DG : Increased energy expenditure associated with repetitive involuntary movement does not contribute to growth failure in girls with Rett syndrome. J Pediatr 1998;132:228-233.

27.

Torres-Aleman I. , Barrios V. , Berciano J. : The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 1998;50: 772-776.

28.

Beck KD , Powell-Braxton L. , Widmer H-R. , et al: IGF-I gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons . Neuron 1995;14:717-730.

29.

Carson MJ , Behringer RR , Brinster RL , McMorris FA : Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993 ;10:729-740.

30.

Woods KA , Camacho-Hübner C. , Savage MO , Clark Ajl : Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl JMed 1996; 335:1363-1367.

31.

Doré S. , Kar S. , Quirion R. : Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997;20:326-331.

32.

Glick RP , Unterman TG : Radioimmunoassay of insulin-like growth factors I and II in the cerebrospinal fluid of patients with pituitary and other central nervous system tumors. Neurosurgery 1995;36: 556-564.

33.

Torres-Aleman I. , Barrios V. , Lledo B. , Berciano J. : The insulin-like growth factor I system in cerebellar degeneration. Ann Neurol 1996;39:335-342.

34.

Riikonen R. , Somer M. , Turpeinen U. : Low insulin-like growth factor (IGF-I) in the cerebrospinal fluid of children with PEHO syndrome (progressive encephalopathy, hypsarrhythmia and optic atrophy) and cerebellar degeneration. Epilepsia 2000;40: 1642-1648.

35.

Bauman ML , Kemper TL : Histoanatomic observations of the brain in early infantile autism. Neurology 1985;35:866-874.

36.

Bauman ML , Kemper TL , Arin DM : Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995;45:1581-1586.

37.

Subramaniam B. , Naidu S. , Reiss A. : Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa. Neurology 1997;48: 399-407.

38.

Juul A. , Bang P. , Hertel NT , et al: Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.